valued at approximately ₹177 Crore on Monday, May 25.
The hospital chain said it will acquire the 330-bed hospital in an all-cash deal through a two-tranche share purchase. According to the exchange filing, 80% of the stake will be acquired by August 31, 2026, with the remaining 20% to be completed by April 30, 2030.
Incorporated in July 2014, Medicity Hospital has over 20 speciality departments, including Cardiac Sciences, Neurosurgery, Orthopaedics, Oncology & Oncosurgery, Obstetrics & Gynaecology, IVF & Infertility, Nephrology, Gastroenterology, ENT, Paediatrics, Urology, Physiotherapy, Dialysis, Blood Bank, Interventional Radiology, and more.
Also read: It’s time to invest in equities, not hold cash, says Renaissance’s Pankaj Murarka
Medicity is the largest hospital in the Kumaon region, spanning over 7,000 square meters of land with approximately 1.64 lakh square feet of covered area, according to the press release filed with the exchanges.
“The Medicity Hospital, Rudrapur, is a high-quality, well-entrenched asset with a strong clinical reputation and an established patient base — precisely the profile we seek in our inorganic growth initiatives,” Ankit Gupta, Managing Director, Park Medi World was quoted as saying.
He added, “Its strategic location within the Kumaon region, combined with its NABH accreditation and advanced infrastructure, positions it as a cornerstone asset within our expanding cluster-based network.”
The acquired entity reported revenue of ₹55.74 crore in financial year 2026, ₹49.04 crore in financial year 2025 and ₹42.4 crore in financial year 2024.
Medicity also said that the hospital is among the select NABH-accredited institutions in the region, reflecting a “commitment to the highest standards of clinical governance, patient safety, and operational quality.”
With this acquisition, Park Medi has expanded into a sixth state in India, and it “meaningfully strengthens Park Group’s presence across key geographical areas in North India, advancing its long-term objective of building a dominant and integrated healthcare network in the region,” the company said.
The newest addition is expected to further strengthen the consolidated financial performance of Park Group.
The company plans to enhance clinical service offerings, optimise operational workflows, and implement a structured drive to improve bed utilisation rates, “all of which are anticipated to deliver meaningful improvements to revenue and profitability over the medium to long term,” it added.
In an interaction with CNBC-TV18, Group CEO And Whole-time Director Sanjay Sharma said that the acquisition will be funded through internal accruals, adding that the hospital chain will add another 500 beds in financial year 2027, with another 1,000 bed target in financial year 2028.
Shares of Park Medi World are trading 7.6% higher at ₹279.33. The stock is up 18% in the last one month and are up 87% so far in 2026.
